AngioDynamics

AngioDynamics Employees

The The number of employees of AngioDynamics (ANGO) as of Nov 2, 2026 is 632. In the previous year, The number of employees was 632.00 — a change of 0.00% (lower).

Employees

632

YoY

0.00%

Last updated:

In 2026, AngioDynamics employed 632 people, a 0.00% change from the 632.00 number of employees in the previous year.

The AngioDynamics Employees history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Employees
Date
Employees
Jan 1, 2019
632.00 USD
Jan 1, 2020
632.00 USD
Jan 1, 2021
632.00 USD
Jan 1, 2022
632.00 USD
Jan 1, 2023
632.00 USD
Jan 1, 2024
632.00 USD
Jan 1, 2025
632.00 USD
Jan 1, 2026
632.00 USD
The AngioDynamics Employees history
YEAREmployeesYoY
6320.00%
6320.00%
6320.00%
6320.00%
6320.00%
6320.00%
6320.00%
6320.00%
6320.00%
6320.00%
6320.00%
6320.00%
632—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

Employees Details

Examining AngioDynamics's Employee Base

AngioDynamics's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding AngioDynamics's operational capacity and future potential.

Year-to-Year Comparison

Assessing AngioDynamics's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

AngioDynamics's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in AngioDynamics’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about AngioDynamics stock

The number of employees of AngioDynamics is 632 in 2026.

The number of employees of AngioDynamics changed from 632.00 to 632, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of employees AngioDynamics since 2006 – with annual values, charts, and detailed analysis.

The number of employees describes the number of people directly employed by the company.

The number of employees's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The number of employees's AngioDynamics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — AngioDynamics

All Key Metrics — AngioDynamics